NIT
ALDR

NumerixS Investment Technologies’s Alder Biopharmaceuticals ALDR Stock Holding History

NumerixS Investment Technologies’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,100
Closed -$13K – 1356
2019
Q2 		$13K Buy
+1,100
New +$13.3K ﹤0.01% 956
2018
Q3 		– Sell
-100
Closed -$2K – 1447
2018
Q2 		$2K Sell
100
-17,300
-99% -$263K ﹤0.01% 1083
2018
Q1 		$211K Buy
17,400
+300
+2% +$4.34K 0.05% 383
2017
Q4 		$196K Sell
17,100
-3,500
-17% -$39.1K 0.04% 467
2017
Q3 		$252K Sell
20,600
-30,700
-60% -$320K 0.06% 448
2017
Q2 		$587K Buy
51,300
+32,000
+166% +$592K 0.09% 289
2017
Q1 		$401K Buy
19,300
+18,000
+1,385% +$398K 0.05% 501
2016
Q4 		$27K Sell
1,300
-7,100
-85% -$185K ﹤0.01% 1019
2016
Q3 		$275K Buy
+8,400
New +$256K 0.04% 580

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NumerixS Investment Technologies's ALDR Position: Q3 2019 in Review

NumerixS Investment Technologies sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 1,100 shares — an estimated $13K sold.

NumerixS Investment Technologies first reported a position in ALDR in Q3 2016 and held it in 9 quarters. The position peaked at $587K in Q2 2017. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • NumerixS Investment Technologies reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,100 Alder Biopharmaceuticals shares in Q3 2019, an estimated $13K.
  • NumerixS Investment Technologies first reported a position in Alder Biopharmaceuticals in Q3 2016 and held it in 9 quarters.
  • NumerixS Investment Technologies's Alder Biopharmaceuticals position peaked at $587K in Q2 2017.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on NumerixS Investment Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.